hydroxychloroquine has been researched along with gemifloxacin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Al-Ghussein, MA; Al-Masri, IM; Atallah, N; Bustanji, Y; Mohammad, M; Taha, MO; Zalloum, H | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
1 review(s) available for hydroxychloroquine and gemifloxacin
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 other study(ies) available for hydroxychloroquine and gemifloxacin
| Article | Year |
|---|---|
Pharmacophore modeling, quantitative structure-activity relationship analysis, and in silico screening reveal potent glycogen synthase kinase-3beta inhibitory activities for cimetidine, hydroxychloroquine, and gemifloxacin.
Topics: Algorithms; Binding Sites; Cimetidine; Computer Simulation; Enzyme Inhibitors; Fluoroquinolones; Gemifloxacin; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Hydroxychloroquine; Linear Models; Models, Molecular; Molecular Structure; Naphthyridines; Predictive Value of Tests; Quantitative Structure-Activity Relationship; Sequence Analysis, Protein; Software | 2008 |